Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/13/24 16:30 | 6/12/24 | FGEN | Health | Drug | Pharmaceutical Preparations | Adib Deyaa | CA | O | Chief Me | P | 26 | 1.17 | 0 | 22 | 37 | 82 | D | ||||||||||||||
3/11/24 19:06 | 3/7/24 | FGEN | Health | Drug | Pharmaceutical Preparations | Wettig Thane | CA | O | CEO | P | 95 | 1.91 | 0 | 50 | 12 | 471 | D | ||||||||||||||
8/30/21 20:11 | 8/26/21 | FGEN | Health | Drug | Pharmaceutical Preparations | Wettig Thane | CA | O | Chief Co | P | 36 | 11.53 | 0 | 3 | 7 | 49 | D | ||||||||||||||
6/12/20 06:59 | 6/10/20 | FGEN | Health | Drug | Pharmaceutical Preparations | Conterno Enrique A | CA | DO | CEO | P.m | 989 | 35.57 | 0 | 28 | 46 | 88 | I | ||||||||||||||
12/5/17 19:45 | 12/4/17 | FGEN | Health | Drug | Pharmaceutical Preparations | Lema Gerald | CA | D | P | 163 | 46.70 | 0 | 4 | New | 4 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |